New York, NY -- (SBWIRE) -- 01/25/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: Generex Biotechnology Corporation (OTCMKTS:GNBT), Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), Plug Power Inc (NASDAQ:PLUG), Hemispherx BioPharma, Inc (NYSEMKT:HEB).
Generex Biotechnology Corporation (OTCMKTS:GNBT) ended its recent business day with the advanced of 16.59% and closed at the price of $0.0513 after opening at $0.04. The stock traded during its last trading session with the total volume of 24.43 million shares, as compared to its average volume of 6.77 million shares. Generex Biotechnology Corporation, a development stage company, is engaged in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases.
Will GNBT Continue To Move Higher? Find out via this report
Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) remained among the day bullish -5.26% and traded with volume of 16.45 million shares in the last session, as compared to average volume of 12.23 million shares. In comparison with 52 week range of $0.28 - $1.85, it faced lowest price of $0.87 during the last trading session whereas its day highest price was $1.05. The company’s total market capitalization is $146.72 million, along with 146.72 million shares outstanding. Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for cancer, central nervous system disorders, sexual dysfunction, and other medical needs.
Will RNN Continue To Move Higher? Find out via this report
Plug Power Inc (NASDAQ:PLUG) showed 15.67 million shares in volume during the last trading session, while the average trading volume remained 26.05 million shares. The stock kicked off its trading session at $2.96 and closed at $2.81 after dropped -8.93%. Plug Power Inc., an alternative energy technology provider, engages in the design, development, commercialization, and manufacture of fuel cell systems for the industrial off-road markets worldwide.
Will PLUG Get Buyers Even After The Recent Rally? Find Out Here
Hemispherx BioPharma, Inc (NYSEMKT:HEB) stock traded during its last trading session with the total traded volume of 8.44 million shares versus its average volume of 4.37 million shares. The company opened its trade at the price of $0.53 and its closing price was $0.510 after fell -7.27% for the day. Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.
Has HEB Found The Bottom and Ready To Move Up? Find Out Here
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts.
Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)